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The behavior of a strain of Neurospora crassa carrying the pyrimi-
-dineless gene 3a (37301) and s, a second mutant gene which suppresses the
effect of 3a, has been described briefly in an earlier publication.1 A strain
carrying 3a alone has an absolute requirement for pyrimidine, while 3a-s
reaches about one-half the maximum growth of the wild type on the un-
-supplemented basal medium.2 However, if arginine is present in this
medium the pyrimidine requirement is again manifested. The effect of
arginine may be suppressed in turn by the addition of lysine. This re-
sponse to arginine and lysine suggested the possibility that one or both of
these amino acids are involved in the biosynthesis of pyrimidines. More
recent investigations have provided evidence that a relationship does
exist, but its nature is not yet understood.
Of the two lines of evidence which indicate this interrelation perhaps the
most convincing is the fact that two of four noh-allelic lysineless mutants3
accumulate pyrimidine compounds in their culture media. One of the com-
pounds has been isolated and identified as uracil. A second substance,
more active biologically, has been shown to be present but has not been
isolated. There is some evidence which suggests that this compound is
uridine.
A gtcond line of evidence is based on growth responses of multiple mutant
strains derived from crosses of lysineless mutants to pyrimidineless 3a-s.
The unexpected behavior of several of these strains has not been satis-
factorily interpreted, but, in the opinion of the authors, such an inter-
pretation must involve an interrelation in the metabolism of pyrimidines
and lysine, and, possibly of arginine as well.
Accumulation of Pyrimidines by Lysineless Strains.-Four lysineless
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mutants, shown by Doermann3 to be non-allelic, have been tested. The iso-
lation numbers are 33933, 37101, 4545 and 15069; for simplicity they will
be called ly 1, 2, 3 and 4. After the finding by Borsook, et al.,4 that lysine
is converted to a amino adipic acid by mammalian tissue slices and homo-
genates it was shown' that this amino acid can be used as a substitute for
lysine by strain ly 1 but not by ly 2, 3 and 4.5 From this it is inferred that
the reaction blocked in strain ly 1 precedes those blocked in the other strains.
Accumulated pyrimidine compounds have been demonstrated in culture
fluid from ly 3 and 4 but not in that from ly 1 and 2. The amount found, in
terms of cytidine sulfate activity for the pyrimidineless strain 3a, varied
from 0.1 to 0.2 mg. in 10 ml. of culture fluid. The substances promote
growth of three non-allelic pyrimidine-requiring strains, 37301 or 3a, 263
and 38502.6 The accumulation was observed in four-day cultures contain-
ing 1 mg. of L(+) lysine monohydrochloride in 20 ml. of medium. This
quantity of lysine is sufficient to allow half-maximum growth of the lysine-
less strains. When higher lysine concentrations were used little or no
pyrimidine activity was detected.
Of the four lysineless strains, 1 and 3 have been more thoroughly tested.
In repeated experiments ly 3 has not failed to show the accumulation under-
the conditions given above while ly 1 has.always failed to do so. Moreover,
no accumulation by the double mutant ly 1-ly 3 has been observed. In
three experiments with ly 2 and ly 4 the former has behaved like ly 1 and the
latter like ly 3. Culture fluid from wild type (Abbott 4) and from an ade-.
nine-requiring strain '27663-44206 supplied a limiting quantity of adenine,
showed no biological activity for the pyrimidineless strains.
Uracil was isolated from a culture of ly 3 grown four days at 25°C. in a
five-gallon bottle containing 15 1. of basal medium supplemented with 750
mg. of L(+) lysine monohydrochloride. The material was first con-
centrated by adsorption on Norite (2 mg. per ml. of culture fluid) and
elution with boiling 10% aniline solution. The active compounds were then
precipitated by the addition of excess silver nitrabte at about pH 8. .Silver
was removed as the sulfide, the volume reduced by evaporation and crystal-
line compound was obtained. After two recrystallizations from hot water
the compound melted with decomposition at 335°C. (corr.). Literature
values for uracil are 338°C., 335°C. The ultra-violet absorption spectrum
was identical to that of uracil and the biological activity for pyr 3a was also
the same.
It seems clear that all of the biological activity found is not due to uracil.
The activity of a number of partially purified preparations exceeded by a
considerable margin that of the quantity of uracil which will remain dis-
solved in the same volume of water. Moreover, solutions of such highly
active preparations showed the maximum absorption of ultra-violet light
at the same wave-length (259 m,) in 0.1 N NaQH as in 0.1 N HCL. This
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is characteristic of the spectrum of uridine, while solutions of uracil, on the
other hand, show a change from 259 m,u in acid to 283 m,u in alkali.
It was found that a small quantity of cytidine, which has the same bio-
logical activity as uridine (about 30 times that of uracil6) will greatly
enhance the activity of uracil. A mixture of 0.1 mg. of cytidine sulfate and
1.6 mg. of uracil is equivalent in activity to 8 mg. of uracil alone. It seems
safe to conclude, therefore, that a pyrimidine derivative with the activity
of uridine or cytidine is also accumulated. The ultra-violet absorption
spectra mentioned above indicate that it is uridine.
TABLE 1
REQUIREMENTS FOR HALF-MAXIMUM GROWTH OF SINGLE AND MULTIPLE MUTANT
STRAINS
STRAIN REQUIREMBNT-MICROMOLS/20 ML. MEDIUM
s 0
pyr 3a cytidine sulfate 1.6; uracil 54.0
cytidine sulfate 0.31 + uracil 2.7
pyr 3a-s 0
ly 1 L-lysine 5.5
DL a amino adipic acid 6.2
ly 1-s . L-lysine 5.5
DL ca amino adipic acid 25. 0
DL a amino adipic acid 6.2 + L-arginine 0.47
DL a amino adipic acid 6.2 + DL citrulline 5.7
DL a amino adipic acid 6.2 + DL ornithine 12. 0
ly 1-pyr 3a L-lysine 5. 5 + cytidine sulfate 1. 6
DL ca amino adipic acid 6. 2 + cystidine sulfate 1. 6
+ L-lysine 0.55
ly 1-pyr 3a-s L-lytine 5.5
ly 3 L-lysine 5.5
ly 3-s L-lysine 5.5
ly 3-pyr 3a L-lysine 5. 5 + cytidine sulfate 1. 6
ly 3-pyr 3a-s L-lysine 5.5 + cytidine sulfate 1.6 + L-arginine 2.4
Double and Triple Mutants Involving Ly 1; Pyr 3a and s.-The requirement
for lysine due to the mutant gene ly 1 is not affected by the presence, in the
same strain, of s or pyr 3a, nor is the pyrimidine requirement or pyr 3a
altered by the presence of ly 1. Growth of the triple mutant ly 1-pyr 3a-s,
when supplied adequate lysine, parallels that of pyr 3a-s on the unsupple-
mented basal medium. However, with respect to their ability to use a amino
adipic acid as a substitute for lysine each of the three strains, ly 1-s, ly 1-
pyr 3a and ly 1-pyr 3a-s differs from strain ly 1.
The quantity of a amino adipic acid required to initiate growth of strain
ly 1-s is about ,four times that which is necessary for half-maximum growth
of ly 1, but if arginine, citrulline or ornithine is added then the response
of this strain is very nearly like that of the single mutant. Citrulline is less
effective than arginine and ornithine-is still less effective; also the effect of
the latter is rather erratic. The quantities required are given in table 1.
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This response to these amino acids is of particular interest because of their
effect upon the lysineless strains and upon pyr 3a-s. Their presence in the
culture medium inhibits the utilization of lysine by all of the lysineless
strains7 and prevents growth of strain pyr 3a-s in the absence of pyrimidine.1
The relative effectiveness of arginine, citrulline and ornithine is the same in
the three cases.
Strain ly 1-pyr 3a does not grow when supplied a amino adipic acid with
cytidine and canhot be made to do so by, the addition of arginine, ci-
trulline or ornithine. However, if a small quantity of lysine is added, about
one-tenth the requirement for half-maximum growth, then, in the presence
of adequate cytidine, the response of this strain to a amino adipic acid is
like that of ly 1. Utilization of this compound by ly 1-s is apparently not
affected by lysine. When supplied lysine in addition to quantities of ca
amino adipic acid smaller than that required to initiate growth, this
strain responds as it does to the same quantity of lysine alone.
Utilization of a amino adipic acid by ly 1-pyr 3a-s has not been
demonstrated although the following additions have been tried: lysine;
arginine plus cytidine; and lysine plus arginine plus cytidine.
No inhibitory effects have been observed of cytidine upon the utilization
of a amino adipic acid by strain ly 1, nor of this amino acid upon the utili-
zation of cytidine by pyr 3a. Growth of strain pyr 3a-s is not affected by
a amino adipic acid. 0
Double and Triple Mutants Involving Ly 3, Pyr Sa and s.-Require-
ments for lysine and cytidine of the double mutants ly 3-s and ly 3-pyr 3a,
like the corresponding combinations with ly 1, have not been found to differ
from those of the single mutants. Strain ly 3-pyr 3a-s, on the other hand,
departs markedly from the behavior which would be predicted for it on
the basis of characteristics of the single and double mutants involving these
three genes. It does not grow when supplied lysine alone, but requires
pyrimidine and arginine as well. Moreover, in order to allow maximum
growth, lysine and arginine must be supplied in a molar ratio of 2.3 to 1.
The requirement for pyrimidine is not surprising since the suppressor
does not function if arginine is present unless the lysine concentration is
about six times that of arginine. When lysine and arginine are supplied
in suitable concentrations then the response of this strain to cytidine is the
same as that of pyr 3a. Table 1 lists the requirements for half-maximum
growth of the various single and multiple mutant strains.
There are two points of similarity between ly 3-pyr 3a-s and the argi-
nineless mutant 36703. First, neither citrulline nor ornithine will satisfy
the arginine requirement.8 Second, both strains are inhibited by lysine if
the molar ratio of lysine concentration to arginine concentration is 3.5 to 1
or greater. For this reason strains of the constitutions arg-s and arg-pyr
3a were considered of possible interest and were prepared. However, no
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departures from predicted behavior have been observed. Arg-s responds to
arginine and lysine as does arg alone, while requirements of arg-pyr 3a for
arginine and cytidine are like those of arg and pyr 3a. Combinations in-
volving arg and ly 1 or ly 3 may prove of interest but they have not yet been
obtained.
Verification of Genetic Constitution of Multiple Mutant Strains.-The
various double and triple mutants were obtained from crosses of pyr 3a-s
to ly 1, ly 3 and arg. Ly 1-s, ly 3-s and arg-s were selected from asci contain-
ing four spores carrying pyr 3a alone. The other four spores would, of
course, carry s along with the third mutant gene involved in the cross. The
double mutants of pyr 3a with ly 1, ly 3 or arg were obtained from asci
which gave rise to four wild-type appearing strains and four having the
appropriate double requirement, lysine plus pyrimidine or arginine plus
pyrimidine. Ly 1-pyr 3a-s came from an ascus from which were obtained
four wild-type appearing strains and four requiring only lysine. The ascus
from which ly 3-pyr 3a-s was derived gave rise to four wild-type strains and
four which failed to grow when supplied lysine plus cytidine. The identity
of these two strains was further checked by recovering from crosses to wild-
type strains carrying pyr 3a-s and others requiring lysine alone or lysine plus
pyrimidine. Arg-pyr 3a had, of course, to be crossed to wild type in order
to distinguish it from arg-pyr 3a-s.
In the case of each multiple mutant described, isolates from several
different- asci were tested and found to have the same characteristics.
Discussion.-The fact that obstruction of the biosynthesis of lysine at
either of two points results in accumulation of pyrimidines, while in-
terruption of the series at two other points does not produce this result,
establishes an interdependence in the metabolism of pyrimidine and lysine
in Neurospora. Such a relationship is also strongly indicated by the fact
that introduction of a genetic block in the series of reactions by which the
pyrimidine ring is synthesized interferes with the utilization of a precursor
of lysine, a amino adipic acid, by strain ly 1-pyr 3a. The behavior of ly 1-s
and ly 1-pyr 3a-s, as well as that of ly 1-pyr 3a, suggests that utilization of
this compound is dependent upon the pyr 3a reaction.
No satisfactory scheme has been devised which will explain how lysine
metabolism is related to pyrimidine biosynthesis and in what way arginine
is involved.
Summary.-Of four non-allelic lysineless strains two have been shown to
accumulate pyrimidines, while two do not. One of the accumulated com-
pounds has been isolated and identified as uracil. Another has been
tentatively identified as uridine.
Tht double and triple mutant combinations of the pyrimidineless gene,
3a and its suppressor, s, with two lysineless strains have been prepared and
tested. Several of these show growth responses, not characteristic of the
,A4g
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single mutants involved, which indicate a relationship. in the metabolism
of pyrimidines, lysine and arginine. Combination of the genes, lysineless
3, pyrimidineless 3a and s introduces a requirement for arginine. Lysineless
strain 1 is able to use a amino adipic acid as effectively as it uses
lysine. Combination of this gene with the suppressor gene s produces a
strain which has the same requirement for lysine as lysineless 1, but a much
higher requirement for a amino adipic acid, unless arginine, citrulline or
ornithine is also supplied. By combination, of this lysineless gene with
pyrimidineless 3a a strain is produced which cannot use a amino adipic acid
unless a small amount of lysine is added.
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It is generally agreed that the number of chromosome breaks initially
produced by a given dose of x-rays is independent of conditions at the time
of radiation. But the subsequent yield of observable chromosomal
aberrations from a given number of initial breaks depends upon the ratio
of those breaks which rejoin (and are not detectable) to, those which do
not rejoin or which rejoin in detectable new associations. The majority
of the breaks produced by x-radiation, under normal conditions, seem to
rejoin in their original position and do not form observable aberrations.3
Any factors which affect this process.of rejoining will influence the yield
of chromosomal aberrations obtained from a given x-ray dose. Several
treatments used in conjunction with x-rays have been shown to increase
(or decrease) the yield as compared with that obtained from the same dose
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